Announcement on Resignation of Director
Filed with SSE · · 2 pages · Chinese
Shouyao Holdings Beijing Co. Ltd. on 6ix
Earlier from Shouyao Holdings Beijing
- Announcement on Retirement and Resignation of Core Technical Personnel
- Announcement on Voluntary Disclosure of MAT2A Inhibitor SY-9453 Obtaining the Notice of Approval for Drug Clinical Trials
- Preliminary Earnings Estimate for 2025
- Announcement on Obtaining Government Subsidies
- Report for Q3 2025
Later from Shouyao Holdings Beijing
- Announcement on the Adjustment of the Collaborative R&D Model for JAK2 Inhibitor Antitumor New Drugs
- Announcement on Expanding Business Scope, Amending the Articles of Association and Handling Industrial and Commercial Change Registration
- Announcement on Resolutions of the 14th Meeting of the 2nd Board of Directors
- Announcement on Voluntary Disclosure of Approval of ALK Inhibitor Conteltinib Granules (Shouyaoze®) for Marketing by the National Medical Products Administration
- Announcement on Resolutions of the 2025 Annual General Meeting
Follow Shouyao Holdings Beijing into a list and get an email when it puts out news.
Follow Shouyao Holdings Beijing